A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Atypical Ductal Breast Hyperplasia|Breast Cancer|Ductal Breast Carcinoma in Situ|Lobular Breast Carcinoma in Situ
Interventions: DRUG: atorvastatin calcium|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)